← Leaderboards
Marla Popov
Glycoscientific, Llc
$2,285,081
Attributed
$2,285,081
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $875.8K · FY2017–23$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,285,081 · 4
By mechanism
R44$1,110,831 · 1
N43$600,000 · 1
R43$574,250 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Antibodies”
- Bambra Strokes · Ppd Development Lp$461,655,950
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$169,304,044
- Yunda Huang · Fred Hutchinson Cancer Center$73,421,550
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Hanjoon Ryu$28,519,898
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$27,369,420
Research focus
AntibodiesMonoclonal AntibodiesImmune SystemModificationWestern BlottingGlucosamineProteinsSiteImmunizationResearch PersonnelProtein-Carbohydrate InteractionSpecificityImmunoprecipitationEnzymesAffinityProductionUdp-N-Acetylglucosamine-Peptide Beta-N-AcetylglucosaminyltransferaseCellsSugarCell PhysiologyResponsePlayReagentAutoantigens
Grant awards (8)
Development of Monoclonal Antibodies for the Study of Mycobacterium tuberculosis (Mtb) in the Guinea Pig$600,000
N43 · FY2023 · AI · contact PI
Recognition of O-GlcNAc Modified Proteins Using Site-Specific Antibodies$275,767
R43 · FY2023 · HL · contact PI
Development of Site-specific Arg-GlcNAc Antibodies$148,483
R43 · FY2020 · GM · contact PI
Development of Site-specific O-GlcNAc Antibodies for Epigenetic Research$350,000
R44 · FY2019 · GM · contact PI
Development of Site-specific Arg-GlcNAc Antibodies$150,000
R43 · FY2019 · GM · contact PI
Development of Site-specific O-GlcNAc Antibodies for Epigenetic Research$350,000
R44 · FY2018 · GM · contact PI
Development of Site-specific O-GlcNAc Antibodies for Epigenetic Research$60,832
R44 · FY2018 · GM · contact PI
Development of Site-specific O-GlcNAc Antibodies for Epigenetic Research$349,999
R44 · FY2017 · GM · contact PI